Phase 2 open-label study of MEDI-551 and bendamustine versus rituximab and bendamustine in adults with relapsed or refractory CLL.
Douglas Edward Gladstone
Research Funding - MedImmune
Marc Andre
Research Funding - MedImmune
Jan M. Zaucha
Research Funding - MedImmune
Sarit E. Assouline
Research Funding - MedImmune
Naresh Bellam
Research Funding - Facet Biotech; Genentech; Janssen; MedImmune
Nicola Cascavilla
Research Funding - MedImmune
Eric Jourdan
Research Funding - MedImmune; Roche
Amit W. Panwalkar
Research Funding - MedImmune
Caterina Patti
Research Funding - MedImmune
Clemens Schulte
No relevant relationships to disclose
Francesco Zaja
Research Funding - MedImmune
Trishna Goswami
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
Nairouz Elgeioushi
Employment or Leadership Position - MedImmune
Stock Ownership - AstraZeneca
David Spaner
Research Funding - MedImmune